NR4A1 and cancer: Again, no difference in time to cancer recurrence (DFS) was observed between patients who became pregnant or did not become pregnant, regardless of whether they were diagnosed with hormone receptor positive (hazard ratio [HR] = 0.94, 95% confidence interval [CI] = 0.70 to 1.26, p = 0.68) or hormone receptor negative (HR = 0.75, 95% CI = 0.53 to 1.06, p = 0.10) cancer.